A. Gauliard

A randomized phase l pharmacokinetic study comparing SB4 and etanercept reference product (Enbrel®) in healthy subjects

Y. J. Lee, J. Kang, Donghoon Shin, 2016, British journal of clinical pharmacology.

Cutaneous side‐effects in patients with rheumatic diseases during application of tumour necrosis factor‐α antagonists

W. Sterry, M. Worm, G. Burmester, 2007 .

SAT0176 A Phase I Pharmacokinetic Study Comparing SB4, An Etanercept Biosimilar, and Etanercept Reference Product (Enbrel®) in Healthy Male Subjects

J. Kang, Donghoon Shin, R. Fuhr, 2015 .

Mutation and citrullination modifies vimentin to a novel autoantigen for rheumatoid arthritis.

G. Burmester, P. Rudolph, K. Egerer, 2007, Arthritis and rheumatism.

A Randomized Phase I Pharmacokinetic Study Comparing Biosimilar Candidate SB3 and Trastuzumab in Healthy Male Subjects.

X. Pivot, G. Golor, E. Curtit, 2016, Clinical therapeutics.

Cutaneous side-effects in patients with rheumatic diseases during application of tumour necrosis factor-alpha antagonists.

J. Detert, S. Kary, A. Gauliard, 2007, The British journal of dermatology.